Show simple item record

dc.contributor.advisorCastro, Carmen
dc.contributor.advisor
dc.contributor.authorGeribaldi Doldán, Noelia 
dc.contributor.authorCarrasco Viñuela, Manuel 
dc.contributor.authorMurillo Carretero, Maribel
dc.contributor.authorDomínguez García, Samuel 
dc.contributor.authorGarcía Cózar, Francisco José 
dc.contributor.authorMuñoz Miranda, Juan Pedro 
dc.contributor.authordel Río García, Valme
dc.contributor.authorVerástegui Escolano, Cristina 
dc.contributor.authorCastro González, Carmen 
dc.contributor.otherAnatomía y Embriología Humanaes_ES
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2024-02-05T11:17:03Z
dc.date.available2024-02-05T11:17:03Z
dc.date.issued2018-09
dc.identifier.issn2041-4889
dc.identifier.urihttp://hdl.handle.net/10498/30595
dc.description.abstractBrain injuries in the adult mammalian brain are accompanied by a fast neurogenic response inside neurogenic niches. However, this response does not contribute to the generation of new neurons within damaged tissues like the cerebral cortex, which are essentially non-neurogenic. This occurs because injuries create a hostile environment that favors gliogenesis. Overexpression and sequential activation of the ADAM17/TGFα/EGFR signaling cascade are crucial for the generation of this gliogenic/non-neurogenic environment. Here, we demonstrate that chronic local infusion of a general metalloprotease inhibitor in areas of traumatic cortical injury in adult mice moderately increased the number of neuroblasts around the lesion, by facilitating the survival of neuroblasts and undifferentiated progenitors, which had migrated to the perilesional area from the subventricular zone. Next, we generated a dominant-negative version of ADAM17 metalloprotease, consisting of a truncated protein containing only the pro-domain (ADAM17-Pro). Specific inhibition of ADAM17 activity by ADAM17-Pro overexpression increased the generation of new neurons in vitro. Local overexpression of ADAM17-Pro in injured cortex in vivo, mediated by lentiviral vectors, dramatically increased the number of neuroblasts observed at the lesion 14 days after injury. Those neuroblasts were able to differentiate into cholinergic and GABAergic neurons 28 days after injury. We conclude that ADAM17 is a putative target to develop new therapeutic tools for the treatment of traumatic brain injury.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Groupes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceCell Death and Disease, 2018, Vol. 9 n.9 pp. 862.es_ES
dc.subjectneurogenesises_ES
dc.subjecttraumatic brain injuryes_ES
dc.subjectneuroblast migrationes_ES
dc.subjectADAM17es_ES
dc.titleSpecific inhibition of ADAM17/TACE promotes neurogenesis in the injured motor cortexes_ES
dc.typejournal articlees_ES
dc.identifier.urlhttps://www.nature.com/articles/s41419-018-0913-2
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1038/s41419-018-0913-2
dc.relation.projectIDMinisterio de Economía y Competitividad (Grant Number BFU2015-68652-R, MINECO/FEDER)es_ES
dc.relation.projectIDConsejería de Innovación, Ciencia y Empleo, Junta de Andalucía (Grant Numbers P10CTS6639)es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional